LEADER 04992nam 2200649 450 001 9910821407003321 005 20230807212207.0 010 $a0-19-150387-8 010 $a0-19-176165-6 010 $a0-19-150386-X 035 $a(CKB)3710000000315281 035 $a(EBL)1903258 035 $a(SSID)ssj0001433128 035 $a(PQKBManifestationID)11754746 035 $a(PQKBTitleCode)TC0001433128 035 $a(PQKBWorkID)11413199 035 $a(PQKB)10243494 035 $a(MiAaPQ)EBC1903258 035 $a(Au-PeEL)EBL1903258 035 $a(CaPaEBR)ebr10995845 035 $a(CaONFJC)MIL732834 035 $a(OCoLC)898769291 035 $a(EXLCZ)993710000000315281 100 $a20150105h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCognitive impairment and dementia in Parkinson's disease /$fedited by Murat Emre 205 $aSecond edition. 210 1$aOxford, England :$cOxford University Press,$d2015. 210 4$d©2015 215 $a1 online resource (327 p.) 300 $aDescription based upon print version of record. 311 $a1-336-01552-7 311 $a0-19-968164-3 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Contents; Murat Emre; Contributors; 1 Introduction; 2 Epidemiology of dementia associated with Parkinson's disease; Dag Aarsland and Alexandra Bernadotte; 3 General features, mode of onset, and course of dementia in Parkinson's disease; Murat Emre; 4 Cognitive profile in Parkinson's disease dementia; Kolbjørn Brønnick; 5 Neuropsychiatric symptoms in Parkinson's disease dementia; Eugenia Mamikonyan and Daniel Weintraub; 6 Interaction between affect and executive functions in Parkinson's disease; Paolo Barone and Gabriella Santangelo 327 $a7 Motor symptoms and phenotype in patients with Parkinson's disease dementia David J. Burn and Alison J. Yarnall; 8 Interaction between cognition and gait in patients with Parkinson's disease; Jeffrey M. Hausdorff, Jenny Zitser, Anat Mirelman, and Nir Giladi; 9 Disorders of sleep and autonomic function in Parkinson's disease dementia; Eduardo Tolosa, Judith Navarro-Otano,and Alex Iranzo; 10 Structural and functional neuroimaging in patients with Parkinson's disease dementia; Gordon W. Duncan, Michael J. Firbank,and John T. O'Brien 327 $a11 Biomarkers for cognitive impairment and dementia in Parkinson's disease Guido Alves, Kenn Freddy Pedersen,and Jan Petter Larsen; 12 Electrophysiological and other auxiliary investigations in patients with Parkinson's disease dementia; Yasuyuki Okuma and Yoshikuni Mizuno; 13 The genetic basis of dementia in Parkinson's disease; Rita Guerreiro and Andrew Singleton; 14 Neurochemical pathology of Parkinson's disease dementia and dementia with Lewy bodies; David Whitfield, Margaret Ann Piggott, ElaineK. Perry, and Paul T. Francis; 15 Pathological correlates of dementia in Parkinson's disease 327 $aGonzalo J. Revuelta, Guttalu K. Kumaraswamy,and Carol F. Lippa16 Epidemiology, diagnosis, and correlates of mild cognitive impairment in Parkinson's disease; Elise Caccappolo and Karen Marder; 17 The pathophysiological and prognostic heterogeneity of mild cognitive impairment in Parkinson's disease; Sophie E. Winder-Rhodes, Roger A. Barker,and Caroline H. Williams-Gray; 18 Spectrum of Lewy body dementias: relationship of Parkinson's disease dementia to dementia with Lewy bodies; Clive Ballard, Sara Garcia-Ptacek, Inger van Steenoven, and Dag Aarsland 327 $a19 Spectrum of disorders with dementia and parkinsonism Jaime Kulisevsky and Javier Pagonabarraga; 20 Diagnosis of dementia in Parkinson's disease; Murat Emre; 21 Management of Parkinson's disease dementia and dementia with Lewy bodies; Ian McKeith and Murat Emre; 22 Parkinson's disease: what will the future bring?; John Hardy; Index 330 $aIn this edited volume, experts on the treatment of dementia associated with Parkinson's Disease (PD) describe in detail the current status of knowledge in their respective area of expertise. The importance and clinical relevance of cognitive impairment and dementia in PD is emphasized, all relevant aspects including epidemiology, full and detailed spectrum of clinical features, current knowledge on pathology, neurochemistry and genetics, findings in auxiliary investigations, relation to other neurodegenerative disorders, diagnostic process and management are described, rounded-up by discussion 606 $aParkinson's disease 606 $aLewy body dementia 615 0$aParkinson's disease. 615 0$aLewy body dementia. 676 $a616.833 702 $aEmre$b M$g(Murat), 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910821407003321 996 $aCognitive impairment and dementia in Parkinson's disease$93931741 997 $aUNINA